
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-03-31 | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | |
---|---|---|---|---|---|---|
Revenue | $16M | $15.6M | $22.3M | $31.4M | $31.6M | |
Revenue Growth (YoY) | -4.16% | -2.57% | 42.88% | 41.06% | 0.51% | |
Cost of Revenues | $12.9M | $12.1M | $18.9M | $26.5M | $27.5M | |
Gross Profit | $3.1M | $3.5M | $3.4M | $4.9M | $4.1M | |
Gross Profit Margin | 19.61% | 22.21% | 15.15% | 15.6% | 13.04% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $2.8M | $2.8M | $4.9M | $6M | $8.8M | |
Other Inc / (Exp) | -$472.3K | $4.6K | $1.3M | $40.8K | $43.4K | |
Operating Expenses | $2.8M | $2.8M | $4.9M | $5.4M | $8.8M | |
Operating Income | $353.7K | $623.3K | -$1.6M | -$468.7K | -$4.6M | |
Net Interest Expenses | $296.1K | $202.3K | $269.4K | $355.6K | $521.1K | |
EBT. Incl. Unusual Items | -$414.6K | $425.5K | -$542.2K | -$783.4K | -$5.1M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -$73K | $104.9K | -$192.4K | $195.6K | $1.9M | |
Net Income to Company | -$341.6K | $320.6K | -$349.8K | -$979K | -$7M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$341.6K | $320.6K | -$349.8K | -$979K | -$7M | |
Basic EPS (Cont. Ops) | -$0.04 | $0.04 | -$0.04 | -$0.11 | -$0.81 | |
Diluted EPS (Cont. Ops) | -$0.04 | $0.04 | -$0.04 | -$0.11 | -$0.81 | |
Weighted Average Basic Share | $7.3M | $7.4M | $8.6M | $8.6M | $8.7M | |
Weighted Average Diluted Share | $7.3M | $7.8M | $8.6M | $8.6M | $8.7M | |
EBITDA | $599.1K | $1.3M | $1.2M | $1.8M | -$2.2M | |
EBIT | -$118.5K | $627.9K | -$272.8K | -$427.8K | -$4.6M | |
Revenue (Reported) | $16M | $15.6M | $22.3M | $31.4M | $31.6M | |
Operating Income (Reported) | $353.7K | $623.3K | -$1.6M | -$468.7K | -$4.6M | |
Operating Income (Adjusted) | -$118.5K | $627.9K | -$272.8K | -$427.8K | -$4.6M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | $3.6M | $6.5M | $8.3M | $7.7M | $7.6M | |
Revenue Growth (YoY) | -2.66% | 82.41% | 27.89% | -8.13% | -0.37% | |
Cost of Revenues | $2.9M | $6M | $6.8M | $6.5M | $6.6M | |
Gross Profit | $705.4K | $478.1K | $1.5M | $1.2M | $991K | |
Gross Profit Margin | 19.76% | 7.34% | 18% | 15.18% | 13% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $716.4K | $1.6M | $1.2M | $2.2M | $1.7M | |
Other Inc / (Exp) | -$220 | $2K | $250 | -- | $44K | |
Operating Expenses | $716.4K | $1.6M | $1.2M | $2.2M | $1.7M | |
Operating Income | -$10.9K | -$1.1M | $274.3K | -$996K | -$696K | |
Net Interest Expenses | $50.4K | $94.7K | $93.6K | $110K | $147K | |
EBT. Incl. Unusual Items | -$61.5K | -$1.2M | $181K | -$1.1M | -$799K | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -$13.4K | -$333.9K | $47K | -$241K | -- | |
Net Income to Company | -$48.2K | -$904.7K | $134K | -$865K | -$799K | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$48.2K | -$904.7K | $134K | -$865K | -$799K | |
Basic EPS (Cont. Ops) | -$0.01 | -$0.12 | $0.02 | -$0.10 | -$0.08 | |
Diluted EPS (Cont. Ops) | -$0.01 | -$0.12 | $0.02 | -$0.10 | -$0.08 | |
Weighted Average Basic Share | $7.4M | $8.6M | $8.6M | $8.8M | $9.6M | |
Weighted Average Diluted Share | $7.4M | $8.6M | $8.6M | $8.8M | $9.6M | |
EBITDA | $157K | -$697.6K | $824.7K | -$365K | $50K | |
EBIT | -$25.2K | -$1.2M | $274.6K | -$996K | -$652K | |
Revenue (Reported) | $3.6M | $6.5M | $8.3M | $7.7M | $7.6M | |
Operating Income (Reported) | -$10.9K | -$1.1M | $274.3K | -$996K | -$696K | |
Operating Income (Adjusted) | -$25.2K | -$1.2M | $274.6K | -$996K | -$652K |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | $16.5M | $18.8M | $31.5M | $30.5M | $33.2M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $12.7M | $15.6M | $26.3M | $26.8M | $29.7M | |
Gross Profit | $3.8M | $3.2M | $5.2M | $3.7M | $3.5M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $2.8M | $4.2M | $5.8M | $6.6M | $8.5M | |
Other Inc / (Exp) | -$492.1K | $1.3M | -$1.2K | $41.3K | $59.1K | |
Operating Expenses | $2.8M | $4.2M | $5.2M | $6.6M | $8.5M | |
Operating Income | $987K | -$991.1K | -$19.9K | -$2.9M | -$5M | |
Net Interest Expenses | $237.5K | $223.9K | $348.9K | $447.7K | $559.9K | |
EBT. Incl. Unusual Items | $257.4K | $118.8K | -$369.9K | -$3.3M | -$5.5M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $102.6K | -$341.4K | $202.2K | -$377.6K | $2.5M | |
Net Income to Company | $154.8K | $460.3K | -$572.1K | -$2.9M | -$8M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $154.8K | $460.3K | -$572.1K | -$2.9M | -$8M | |
Basic EPS (Cont. Ops) | $0.00 | $0.08 | -$0.04 | -$0.34 | -$0.89 | |
Diluted EPS (Cont. Ops) | -- | $0.04 | -$0.04 | -$0.34 | -$0.89 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | $1.2M | $1.5M | $2.1M | -$562.2K | -$2.2M | |
EBIT | $496.6K | $362.8K | -$13.2K | -$2.9M | -$4.9M | |
Revenue (Reported) | $16.5M | $18.8M | $31.5M | $30.5M | $33.2M | |
Operating Income (Reported) | $987K | -$991.1K | -$19.9K | -$2.9M | -$5M | |
Operating Income (Adjusted) | $496.6K | $362.8K | -$13.2K | -$2.9M | -$4.9M |
Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
---|---|---|---|---|---|---|
Revenue | $14.7M | $23.9M | $23M | $24.6M | -- | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $12.5M | $19.9M | $20.1M | $22.3M | -- | |
Gross Profit | $2.2M | $4.1M | $2.9M | $2.2M | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $3.5M | $4.4M | $5.1M | $4.8M | -- | |
Other Inc / (Exp) | $1.3M | $40.6K | $41K | $56.7K | -- | |
Operating Expenses | $3.5M | $3.8M | $5.1M | $4.8M | -- | |
Operating Income | -$1.3M | $252.9K | -$2.2M | -$2.5M | -- | |
Net Interest Expenses | $181.5K | $260.9K | $353.1K | $391.8K | -- | |
EBT. Incl. Unusual Items | -$139.8K | $32.5K | -$2.5M | -$2.9M | -- | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -$385.8K | $8.8K | -$564.4K | -- | -- | |
Net Income to Company | $246K | $23.8K | -$1.9M | -$2.9M | -- | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $246K | $23.8K | -$1.9M | -$2.9M | -- | |
Basic EPS (Cont. Ops) | $0.04 | $0.00 | -$0.22 | -$0.30 | -- | |
Diluted EPS (Cont. Ops) | -- | $0.00 | -$0.22 | -$0.30 | -- | |
Weighted Average Basic Share | $23.8M | $25.8M | $26.1M | $28.2M | -- | |
Weighted Average Diluted Share | $24.2M | $25.8M | $26.1M | $28.2M | -- | |
EBITDA | $995.2K | $1.9M | -$391.6K | -$392.5K | -- | |
EBIT | $16.7K | $266.8K | -$2.2M | -$2.5M | -- | |
Revenue (Reported) | $14.7M | $23.9M | $23M | $24.6M | -- | |
Operating Income (Reported) | -$1.3M | $252.9K | -$2.2M | -$2.5M | -- | |
Operating Income (Adjusted) | $16.7K | $266.8K | -$2.2M | -$2.5M | -- |
Period Ending | 2020-03-31 | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $930.9K | $2.1M | $1.1M | $534.5K | $138.4K | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $990.3K | $608.1K | $3M | $2.3M | $2.4M | |
Inventory | $1.2M | $1.3M | $2.2M | $2.4M | $3.2M | |
Prepaid Expenses | $576K | $372.2K | $327.8K | $349K | $563.7K | |
Other Current Assets | $30.1K | $7.3K | $1.1M | -- | -- | |
Total Current Assets | $8.2M | $9.9M | $16.1M | $14.6M | $14.8M | |
Property Plant And Equipment | $4.2M | $4.1M | $19.5M | $19.6M | $19.8M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | -- | -- | -- | -- | -- | |
Other Intangibles | -- | -- | -- | -- | -- | |
Other Long-Term Assets | $32.6K | $84.6K | $121.3K | $121.3K | $121.3K | |
Total Assets | $14.6M | $16M | $37.9M | $36.2M | $34.7M | |
Accounts Payable | $185.1K | $500.9K | $3.4M | $2.2M | $1.4M | |
Accrued Expenses | $390.5K | $370.8K | $1.1M | $916.8K | $2.3M | |
Current Portion Of Long-Term Debt | $98K | $2.5M | $4.1M | $1.2M | $7.6M | |
Current Portion Of Capital Lease Obligations | $11.9K | -- | $593.8K | $711.7K | $735.9K | |
Other Current Liabilities | -- | -- | $63.4K | -- | -- | |
Total Current Liabilities | $2.7M | $4.7M | $13.3M | $9M | $17.8M | |
Long-Term Debt | $2.4M | $1.3M | $3.1M | $4.7M | -- | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $5.1M | $6.1M | $22.6M | $21.6M | $26.9M | |
Common Stock | $2.9K | $3K | $860 | $860 | $880 | |
Other Common Equity Adj | $21.7K | $21.8K | -- | -- | -- | |
Common Equity | $9.5M | $9.9M | $15.3M | $14.6M | $7.8M | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $9.5M | $9.9M | $15.3M | $14.6M | $7.8M | |
Total Liabilities and Equity | $14.6M | $16M | $37.9M | $36.2M | $34.7M | |
Cash and Short Terms | $930.9K | $2.1M | $1.1M | $534.5K | $138.4K | |
Total Debt | $2.5M | $3.8M | $7.2M | $6M | $7.6M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $1.3M | $562.5K | $316.2K | $391.3K | $165K | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $1.2M | $2.4M | $2.9M | $2.2M | $2M | |
Inventory | $1.2M | $1.7M | $2.3M | $3.6M | $3.2M | |
Prepaid Expenses | $411.4K | $462.2K | $362K | $653.6K | $371K | |
Other Current Assets | $30.7K | $5.3K | $624.1K | -- | $4K | |
Total Current Assets | $9.4M | $15.4M | $15.9M | $15.2M | $14.1M | |
Property Plant And Equipment | $4.2M | $18.6M | $18.7M | $20.6M | $17.9M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | -- | $930.8K | -- | -- | -- | |
Other Intangibles | -- | -- | -- | -- | -- | |
Other Long-Term Assets | $16.1K | $121.3K | $726.5K | $121.3K | $121K | |
Total Assets | $15.6M | $37.4M | $37.4M | $38.4M | $32.2M | |
Accounts Payable | $510.4K | $2.6M | $1.5M | $1.7M | $1.8M | |
Accrued Expenses | $384.5K | $1.2M | $1.1M | $1.2M | $1.6M | |
Current Portion Of Long-Term Debt | $3.1M | $4.9M | $2.1M | $7.4M | -- | |
Current Portion Of Capital Lease Obligations | $12.6K | $539.7K | $727.8K | $727.7K | $761K | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | $5.2M | $12.3M | $8.6M | $16.6M | $15.9M | |
Long-Term Debt | $716.5K | $3.2M | $4.9M | -- | $19K | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $5.9M | $21.6M | $21.8M | $25.6M | $24.1M | |
Common Stock | $3K | $3.4K | $3.4K | $880 | $1K | |
Other Common Equity Adj | $21.8K | $19.9K | -- | -- | -- | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $9.7M | $15.8M | $15.6M | $12.8M | $8.1M | |
Total Liabilities and Equity | $15.6M | $37.4M | $37.4M | $38.4M | $32.2M | |
Cash and Short Terms | $1.3M | $562.5K | $316.2K | $391.3K | $165K | |
Total Debt | $3.8M | $8.1M | $6.9M | $7.4M | $7.3M |
Period Ending | 2020-03-31 | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$341.6K | $320.6K | -$349.8K | -$979K | -$7M | |
Depreciation & Amoritzation | $717.6K | $704.1K | $1.5M | $2.2M | $2.4M | |
Stock-Based Compensation | $90.9K | $179.9K | $190.8K | $309.4K | $1.4M | |
Change in Accounts Receivable | -$93.7K | -$645.6K | $169.8K | $75.2K | $386.3K | |
Change in Inventories | $22.7K | -$53.5K | -$42.5K | -$177.9K | -$837.1K | |
Cash From Operations | $676.8K | $635.9K | $257.8K | $3.1M | $1.3M | |
Capital Expenditures | $39.8K | $617.5K | $939K | $2.3M | $3.2M | |
Cash Acquisitions | -- | -- | -$7.8M | -- | -- | |
Cash From Investing | -$39.8K | -$607.9K | -$8.7M | -$2.3M | -$3.2M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | $2.3M | $8.6M | $10.9M | $7.2M | |
Long-Term Debt Repaid | -$1.7M | -$1.1M | -$4.2M | -$12.2M | -$5.6M | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -$41.6K | -$24.6K | -$505.3K | -$57.7K | -$50.4K | |
Cash From Financing | -$1.7M | $1.2M | $7.4M | -$1.3M | $1.5M | |
Beginning Cash (CF) | $2M | $930.9K | $2.1M | $1.1M | $534.5K | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$1.1M | $1.2M | -$1.1M | -$517.7K | -$396.1K | |
Ending Cash (CF) | $930.9K | $2.1M | $1.1M | $534.5K | $138.4K | |
Levered Free Cash Flow | $636.9K | $18.3K | -$681.2K | $812.5K | -$1.9M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$48.2K | -$904.7K | $134K | -$865K | -$799K | |
Depreciation & Amoritzation | $182.2K | $462.7K | $550.1K | $631K | $702K | |
Stock-Based Compensation | $33.5K | $79.1K | $8.7K | $187K | $22K | |
Change in Accounts Receivable | $871.1K | -$708.4K | -$1M | $553K | $1.5M | |
Change in Inventories | -$107.3K | -$27.9K | $224.5K | -$849K | $160K | |
Cash From Operations | $399.9K | -$582.2K | -$752.4K | -$78K | -$570K | |
Capital Expenditures | $192.1K | $73.5K | $194.7K | $123K | $1.2M | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$192.1K | -$73.6K | -$187.8K | -$123K | $392K | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | $1M | -$865.1K | $188K | $3.5M | $3.8M | |
Long-Term Debt Repaid | -$1M | -$169.3K | $858.1K | -$3M | -$3.6M | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -$16.3K | -$7K | -$25.1K | -$40K | -$10K | |
Cash From Financing | -$44.1K | $936.9K | $1M | $454K | $211K | |
Beginning Cash (CF) | $1.1M | $281.3K | $235.4K | $138K | $132K | |
Foreign Exchange Rate Adjustment | -$50 | $10 | -- | -- | -- | |
Additions / Reductions | $163.8K | $281.1K | $80.8K | $253K | $33K | |
Ending Cash (CF) | $1.3M | $562.5K | $316.2K | $391K | $165K | |
Levered Free Cash Flow | $207.8K | -$655.8K | -$947.2K | -$201K | -$1.7M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $154.8K | $460.3K | -$572.1K | -$2.9M | -$8M | |
Depreciation & Amoritzation | $691K | $1.2M | $2.1M | $2.3M | $2.8M | |
Stock-Based Compensation | $155.7K | $174.7K | $357.2K | $197.8K | $1.2M | |
Change in Accounts Receivable | -$1.1M | -$1.1M | $692.2K | $1.7M | $177.3K | |
Change in Inventories | -$548.1K | $405.3K | -$577.9K | -$1.3M | $440.9K | |
Cash From Operations | -$272.2K | -$673.2K | $2.8M | $3.4M | -$870.1K | |
Capital Expenditures | $551.5K | $507.2K | $1.8M | $3.8M | $3.2M | |
Cash Acquisitions | -- | -$7.8M | -- | -- | -- | |
Cash From Investing | -$551.5K | -$8.3M | -$1.8M | -$3.8M | -$678.3K | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | -- | $20.9M | $7.6M | |
Long-Term Debt Repaid | -$2.2M | -$775.6K | -$4M | -$20.4M | -$7.8M | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -$34K | -- | -$97.3K | -- | -$281.4K | |
Cash From Financing | $110.8K | $8.3M | -$1.3M | $405.4K | $1.3M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$712.9K | -$692.9K | -$246.3K | $75.3K | -$226.1K | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | -$823.7K | -$1.2M | $1M | -$392.1K | -$4.1M |
Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $246K | $23.8K | -$1.9M | -$2.9M | -- | |
Depreciation & Amoritzation | $978.5K | $1.7M | $1.8M | $2.1M | -- | |
Stock-Based Compensation | $141.2K | $307.6K | $196K | $40K | -- | |
Change in Accounts Receivable | -$1.4M | -$924.2K | $720K | $511K | -- | |
Change in Inventories | $477.9K | -$57.5K | -$1.2M | $50K | -- | |
Cash From Operations | -$1.6M | $870.9K | $1.2M | -$995K | -- | |
Capital Expenditures | $436.5K | $1.3M | $2.8M | $2.8M | -- | |
Cash Acquisitions | -$7.8M | -- | -- | -- | -- | |
Cash From Investing | -$8.2M | -$1.3M | -$2.7M | -$230K | -- | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | $4M | $188K | $10.2M | $10.6M | -- | |
Long-Term Debt Repaid | -$736.5K | -$489.6K | -$8.7M | -$10.9M | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -$451.9K | -$43.9K | -$40K | -$271K | -- | |
Cash From Financing | $8.3M | -$345.6K | $1.4M | $1.3M | -- | |
Beginning Cash (CF) | $4.6M | $1.9M | $944.4K | $315.2K | -- | |
Foreign Exchange Rate Adjustment | -$20 | -- | -- | -- | -- | |
Additions / Reductions | -$1.6M | -$736K | -$143K | $27K | -- | |
Ending Cash (CF) | $3.1M | $1.1M | $800.9K | $341.8K | -- | |
Levered Free Cash Flow | -$2.1M | -$397.4K | -$1.6M | -$3.8M | -- |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.